Fridriksdottir Hafrun
CIK 0001561458
Executive VP, Global R&D
Filings
4
Latest May 19, 2022
Issuers covered
1
Showing
4 of 4
Page 1
Track record
6 of 6 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 6 | 33% | -15.3% | -24.0% | +16.8% | -37.1% |
| 90 days | 6 | 17% | -17.9% | -25.6% | +16.7% | -33.3% |
| 180 days | 6 | 0% | -18.5% | -20.2% | -11.2% | -22.7% |
| 365 days | 6 | 17% | -20.4% | -25.3% | +3.2% | -32.8% |
Issuers
Companies where Fridriksdottir Hafrun has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries Ltd | 4 | May 19, 2022 |
All filings
4 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|